APT Medical Inc
SSE:688617
APT Medical Inc
Other Equity
APT Medical Inc
Other Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
APT Medical Inc
SSE:688617
|
Other Equity
¥502.5k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Other Equity
¥7.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Other Equity
¥84.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jafron Biomedical Co Ltd
SZSE:300529
|
Other Equity
¥119m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
L
|
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
|
Other Equity
¥122.5m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Other Equity
-¥20.4m
|
CAGR 3-Years
5%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
APT Medical Inc
Glance View
APT Medical Inc. is a company embedded in the intricate world of medical devices, specializing in the development, production, and distribution of cardiovascular and peripheral vascular medical products. The company’s foundation rests on its ability to innovate and provide solutions that address the complex challenges faced by healthcare professionals in the treatment of heart and vascular diseases. APT Medical strategically focuses on minimally invasive technologies, which are increasingly preferred for their reduced patient recovery times and overall improvement in procedural success rates. By keeping its pulse on the evolving demands within the healthcare sector, APT Medical efficiently aligns its research and development initiatives to meet the global standards and expectations. Revenue streams for APT Medical Inc. flow primarily from its broad portfolio of interventional medical devices, such as guidewires, balloon catheters, and vascular closure devices. The intricacy of their manufacturing processes, coupled with stringent regulatory requirements, ensures that their offerings are both high in quality and competitively priced. Through a network of strategic partnerships, distribution channels, and a robust export framework, the company extends its reach across several international markets. By maintaining a keen focus on customer service and post-market support, APT Medical not only thrives on initial sales but also secures a steady stream of revenue from recurring purchases and long-term partnerships with healthcare institutions globally.
See Also
What is APT Medical Inc's Other Equity?
Other Equity
502.5k
CNY
Based on the financial report for Dec 31, 2023, APT Medical Inc's Other Equity amounts to 502.5k CNY.
What is APT Medical Inc's Other Equity growth rate?
Other Equity CAGR 1Y
55%
Over the last year, the Other Equity growth was 55%.
You don't have any saved screeners yet